NICE (NASDAQ: NICE) reported Q2 EPS of $2.64, $0.06 better than the analyst estimate of $2.58. Revenue for the quarter came in at $664.4 million versus the consensus estimate of $664.1 million.

GUIDANCE:

NICE sees Q3 2024 EPS of $2.62-$2.72, versus the consensus of $2.69. NICE sees Q3 2024 revenue of $676-686 million, versus the consensus of $687.5 million.

NICE sees FY2024 EPS of $10.60-$10.80, versus the consensus of $10.63. NICE sees FY2024 revenue of $2.71-2.73 billion, versus the consensus of $2.74 billion.

For earnings history and earnings-related data on NICE (NICE) click here.